Screener
Vir Biotechnology, Inc. VIR Net margin
Net margin at other companies
Other financials
Where this comes from
Calculated from Vir Biotechnology, Inc.’s reported figures.
Based on trailing twelve months.
The source filing: Vir Biotechnology, Inc.’s 10-Q, filed August 5, 2026. Open the filing →
- Filed
- Aug 5, 2026, 5:20 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001628280-26-053549
FAQ
- What is Vir Biotechnology, Inc.'s net margin?
- Vir Biotechnology, Inc. (VIR) reported net margin of -83% in Q2 2026.
- How has Vir Biotechnology, Inc.'s net margin changed year-over-year?
- Vir Biotechnology, Inc.'s net margin increased by 97.1% year-over-year, from -2,895.9% to -83%.
- What is the long-term trend for Vir Biotechnology, Inc.'s net margin?
- Over 4 years (2020 to 2025), Vir Biotechnology, Inc.'s net margin has grown at a 13.1% compound annual growth rate (CAGR), from -391.1% to -638.9%.
- What does net margin mean?
- Net income as a percentage of revenue (trailing twelve months). The bottom-line profitability measure after all costs, interest, and taxes.
Ask your AI about Vir Biotechnology, Inc.'s net margin.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude